Loading clinical trials...
Loading clinical trials...
A Phase I/II Study to Assess Safety and Preliminary Evidence of a Therapeutic Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases
Conditions
Interventions
Azeliragon
Stereotactic radiosurgery
+1 more
Locations
1
United States
Miami Cancer Institute at Baptist Health, Inc.
Miami, Florida, United States
Start Date
November 17, 2023
Primary Completion Date
March 16, 2027
Completion Date
August 1, 2027
Last Updated
March 4, 2026
NCT06594926
NCT05671510
NCT01109420
NCT06713993
NCT07549477
NCT07543159
Lead Sponsor
Baptist Health South Florida
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions